| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0088 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |